| Business Summary | | Candela
Corporation
is
engaged
in
the
development
and
commercialization
of
advanced
aesthetic
laser
systems
that
allow
physicians
and
personal
care
practitioners
to
treat
a
wide
variety
of
cosmetic
and
medical
conditions
including
vascular
lesion
treatment
of
facial
spider
veins,
leg
veins,
rosacea,
scars,
stretch
marks,
warts,
port
wine
stains
and
hemangiomas.
Other
applications
include
hair
removal,
removal
of
benign
pigmented
lesions
such
as
age
spots
and
tattoos,
and
microdermabrasion
for
skin
exfoliation.
Intense
light
technology
forms
the
basis
for
most
of
the
Company's
products.
Products
include
GentleLASE
Plus
with
DCD
Cool
Comfort
for
permanent
hair
reduction
and
the
treatment
of
large
leg
veins;
Vbeam
with
DCD
Cool
Comfort
for
treating
all
vascular
lesions;
ALEXlazr
and
YAGlazr,
for
treating
pigmented
lesions
and
tattoos,
and
GentlePeel
microdermabrasion
system
for
skin
exfoliation. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Candela
Corp.
researches,
develops,
manufactures,
markets
and
services
lasers
and
other
devices
used
to
perform
aesthetic
and
cosmetic
procedures.
For
the
nine
months
ended
3/31/01,
revenues
fell
12%
to
$46.6
million.
Net
income
fell
73%
to
$2.6
million.
Revenues
reflect
lower
laser
and
other
product
sales.
Earnings
also
suffered
from
lower
margins
due
to
an
increase
in
sales
discounts
and
a
fluctuating
currency
market. Recent Earnings Announcement For
the
3
months
ended
06/30/2001,
revenues
were
18,177;
after
tax
earnings
were
-43. (Preliminary; reported in thousands of dollars.) | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Kenneth Roberts, 67 Chairman | -- | -- | Gerard Puorro, 53 Pres,
CEO | $387K | $2.0M | F. Paul Broyer, 51 CFO,
Sr. of Fin. and Admin. VP, Treasurer | 209K | 386K | William McGrail, 39 VP-Operations | -- | -- | William Kelley, 45 VP-North
American and Latin American Sales | 248K | 566K | Dollar
amounts are as of 1-July-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|